Answers are grounded in this paper and cite their sources.
Framework guides clinicians in earning trust for AI in oncology, suggesting a structured verification process.
This framework is written for the clinicians who will be asked to supervise autonomous Physical AI in oncology clinical trials, and who must decide, at the bedside, when that reliance is earned. It rests on a single mechanism, verification before generation, in which a software agent proposes a clinical action and a ten-gate verification, validation, and uncertainty quantification examination either accepts it under audit, escalates it to a qualified human, or blocks it before it can reach a patient. The decision to trust is organized as eight plain questions a clinician already asks of any tool: is it competent, is it safe, is it transparent, am I in control, is it equitable, is it reliable, who is accountable, and does it fit my workflow. Each question pairs a clinical concern with a credible, cited fact, and closes on the concrete mechanism, a gate, a record, a role, or a control, that answers it. The aim is not maximal trust but calibrated trust: reliance proportioned to demonstrated capability, avoiding both automation bias and algorithm aversion. The framework draws on a documented lineage, including a surgical-humanoid simulation that passed 172 of 172 automated tests across a ten-gate suite, and on the literature of trust in automation, clinical decision support, and algorithmic bias. Three questions recur throughout: would I let this system near my own family member, can I defend this decision at tumor board, and could I show an auditor exactly what happened and why. The conclusion is an adoption decision a clinician can sign.
No takes yet. Share an insight, caveat, or question.
Kevin Kawchak (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: